Current practices in the management of diabetic nephropathy

Journal of the Royal College of Physicians of Edinburgh

Volumn 43, Issue 4, 2013, Pages 330-333

  Chan, G ^a   Tang, S C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic kidney disease; Clinical trials; Diabetic nephropathy; Proteinuria; RAS blockade; Simultaneous pancreas and kidney transplants

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; RAMIPRIL; TELMISARTAN;

ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; GRAFT SURVIVAL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RENAL PROTECTION; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

CHRONIC KIDNEY DISEASE; CLINICAL TRIALS; DIABETIC NEPHROPATHY; PROTEINURIA; RAS BLOCKADE; SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTS;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY TRANSPLANTATION; PREVALENCE;

EID: 84899987509     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2013.413     Document Type: Article

References (16)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4-14. http://dx.doi.org/10.1016/j.diabres.2009.10.007
2. Akmal M. Hemodialysis in diabetic patients. Am J Kidney Dis 2001; 38 (4 Suppl 1):S195-9. http://dx.doi.org/10.1053/ajkd.2001.27443
3. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93. http://dx.doi.org/10.1056/NEJM198407123110204
4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310:356-60. http://dx.doi.org/10.1056/NEJM198402093100605
5. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ2000; 321:412-9. http://dx.doi.org/10.1136/bmj.321.7258.412
6. Bakris GL, Weir MR, Shanifar S. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003; 163:1555-65. http://dx.doi.org/10.1001/archinte.163.13.1555
7. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329:1456-62.http://dx.doi.org/10.1056/NEJM199311113292004
8. de Zeeuw, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65:2309-20. http://dx.doi.org/10.1111/j.1523-1755.2004.00653.x
9. Barnett AH, Bain SC, Bouter P et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004; 351:1952-61. http://dx.doi.org/10.1056/NEJMoa042274
10. Mann JF, Schmieder RE, McQueen M et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double blind, controlled trial. Lancet 2008; 372:547-53. http://dx.doi.org/10.1016/S0140-6736(08)61236-2
11. Parving HH, Persson F, Lewis JB et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008; 358:2433-46. http://dx.doi.org/10.1056/NEJMoa0708379
12. Parving HH, Brenner BM, McMurray JJ et al. Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 2009; 24:1663-71. http://dx.doi.org/10.1093/ndt/gfn721
13. Port FK, Merion RM, Goodrich NP et al. Recent trends and results for organ donation and transplantation in the United States, 2005. Am J Transplant 2006; 6:1095-100. http://dx.doi.org/10.1111/j.1600-6143.2006.01268.x
14. Nathan DM, Fogel H, Norman D et al. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation 1991; 52:85-91. http://dx.doi.org/10.1097/00007890-199107000-00018
15. Rayhill SC, D'Alessandro AM, Odorico JS et al. Simultaneous pancreaskidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 2000; 231:417-23. http://dx.doi.org/10.1097/00000658-200003000-00015
16. Reddy KS, Stablein D, Taranto S et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003; 41:464-70. http://dx.doi.org/10.1053/ajkd.2003.50057